Pós ASCO GU 24 - Urotelial

Os especialistas Dr. Diogo Bastos e Dr. Andrey Soares, comentam sobre os principais dados apresentados durante o Congresso Americano Geniturinário - ASCO GU 2024.
Minuto: 01:17 - Utility of FDG-PET
Abstract 527: Utility of fluoro-deoxy-glucose positron emission tomography (FDG-PET) to predict a pelvic lymphnode involvement (LNI)inpatient(pts)with muscle-invasive bladder cancer (MIBC) enrolled in neoadjuvant therapy trials.
Minuto: 05:54 - Estudo AMBASSADOR
LBA531: AMBASSADOR Alliance A031501: Phase III randomized adjuvant study of pembrolizumab in muscle-invasive and locally advanced urothelial carcinoma (MIUC) vs observation.
Minuto: 15:31 - Estudo EV-302
LBA530: Enfortumab vedotin (EV) in combination with pembrolizumab (P) versus chemo therapy in previously untreated locally advanced metastatic urothelial carcinoma (la/mUC): Subgroup analyses results from EV-302, a phase 3 global study.
Disponível também em todas as plataformas de podcast: podcasters.spotify.com/pod/sh...
#bioeducation #oncology #gu24 #BIOWatch